Tolvaptan — Dosing in CKD & Dialysis
Tolvaptan (Vasopressin Antagonist): renal dosing adjustments, dialyzability (Dialysis may not be effective (protein binding above 98%, per the labels)), and renal-relevant safety risk for CKD and dialysis patients. Educational reference for nephrology professionals.
Reviewed by Matt · November 16, 2026